OBJECTIVE To investigate the neuroprotective effect and mechanism of eleutheroside B （ELB） on Parkinson’s disease （PD） model mice by regulating the IκB kinase β （IKKβ）/nuclear factor-κB （NF-κB） signaling pathway. METHODS Fifty mice were randomly divided into normal control group， model group， positive control group （selegiline hydrochloride， 10 mg/kg）， and ELB low-dose and high-dose groups （80， 160 mg/kg）， with 10 mice in each group. Each group was given relevant medicine or normal saline intragastrically for 14 consecutive days. Starting from the 10th day of administration， the model group and all administration groups were intraperitoneally injected with 1-methyl-4-phenyl-1，2，3，6-tetrahydropyridine （MPTP） 30 mg/kg， for five consecutive days to establish the chronic PD model. After the last administration for 24 h， six mice were randomly selected from each group to test their behavioral abilities； detect the levels of interleukin-1β （IL-1β）， IL-10， tumor necrosis factor-α （TNF-α） in brain tissue and their mRNA expressions were measured， and positive expression of tyrosine hydroxylase （TH）， protein expressions of TH， α -synuclein （ α -syn）， ionized calcium-binding adaptor molecule 1 （Iba-1）， as well as phosphorylation levels of IKKβ and NF-κB p65 proteins in the brain tissue were detected. The ultrastructure of neurons in substantia nigra was observed. RESULTS Compared with the model group， rotarod endurance time and climbing score of each administration group （except for the ELB low-dose group） were increased significantly （ P ＜0.05）， while the levels and mRNA expressions of IL-1β， TNF-α， α -syn， and Iba-1， as well as phosphorylation levels of IKKβ and NF-κB p65 proteins in brain tissue were decreased significantly （except for TNF-α in the ELB low-dose group）. Conversely， the level and mRNA expression of IL-10 （except for the ELB low-dose group）， TH positive expression and protein expressions were significantly increased （ P ＜0.05）. Typical neurodegenerative pathological changes， such as neuronal karyopyknosis， mitochondrial swelling and vacuolization， and endoplasmic reticulum dilation， all showed varying degrees of improvement. CONCLUSIONS ELB may exert neuroprotective effects by inhibiting the activation of the IKKβ/NF-κB signaling pathway， alleviating inflammatory responses， reducing abnormal α -syn aggregation and neuronal loss， and further improving motor dysfunction in PD mice.

Primary biliary cholangitis （PBC） is a cholestatic autoimmune liver disease characterized by the injury of small intrahepatic bile ducts， and at present， the pathogenesis of PBC remains unclear. Recent studies have shown that bile acid metabolism disorder and gut microbiota imbalance play a key role in the development and progression of PBC， and they form a complex and dynamic interaction network via the “gut-liver axis” and regulate core physiopathological processes such as immune response， metabolic homeostasis， and inflammatory response in a synergistic manner. This article systematically elaborates on the abnormal features of bile acid metabolism and gut microbiota in PBC， discusses their synergistic mechanisms in PBC， and then proposes a combined strategy of targeting bile acid receptors and modulating gut microbiota， in order to overcome the limitations of current treatment modalities and provide new insights and directions for the clinical management of PBC.

Objective To explore the current status,hotspots,and frontier directions in the field of hospital research management.Methods Literature related to hospital research management published from January 1987 to March 2025,as in-dexed in the China National Knowledge Infrastructure(CNKI),was retrieved.The visualization software CiteSpace was used to analyze the publication volume,authors,institutions,and keywords.Results A total of 250 Chinese-language articles were in-cluded.The overall publication volume showed a fluctuating upward trend,with the highest number of publications in 2023,reac-hing 26 articles.Notable institutions with higher publication volumes include Chongqing Traditional Chinese Medicine Hospital,the Medical Department of Nanjing General Hospital of the Nanjing Military Region,Tianjin Medical University Cancer Hospital,and Shengjing Hospital of China Medical University.Key authors with more publications include Zhou Laixin,Xu Dixiong,Liu Yuping,and Sun Meng.High-frequency keywords included"research management","hospital","research projects","re-search funding","public hospitals",and"project management",generating 11 clustering labels and 25 emerging terms.Con-clusion The research on hospital research management in China has evolved from conceptual definition and systematic construc-tion to the exploration of innovative strategies,with increasing depth and breadth.The field has yet to form a large-scale,cross-regional author and institutional cooperation network.High-frequency keywords such as"research management","hospital","research projects","research funding","public hospitals",and"project management"represent hotspots in the research.Keywords such as"public hospitals","design",and"research projects"may become the frontier directions for future research in this field.

Objective To investigate the efficacy and safety of non-intubated thoracoscopic surgery in the treatment of non-small cell lung cancer(NSCLC).Methods A total of 180 NSCLC patients were selected and matched by propensity score proximity matching method.Patients were divided into the group A,the group B,the group C and the group D,with 45 cases each.Patients in the group A underwent non-intubated thoracoscopic surgery epidural anesthesia with single operation hole operation,the group B underwent non-intubated thoracoscopic surgery epidural anesthesia with three operation holes,the group C underwent double-cavity tracheal intubation with general anesthesia with single operation hole operation and the group D underwent double-cavity tracheal intubation with three operation holes under general anesthesia.Anesthesia related indexes,surgical related indexes,CD3+,CD4+,CD4+/CD8+,1-second forced expiratory volume(FEV1),maximal voluntary ventilation(MVV),forced vital capacity(FVC)and complication rate of the 4 groups were compared 1 day before surgery and 1 month after surgery.Results The anesthetic preparation time,first anal exhaust time and first getting out of bed time were shorter in the group A and the group B than those in the group C and the group D,and the dosage of propofol and remifentanil was lower in the group A and the group B than that in the group C and the group D(P＜0.05).Compared with the other 3 groups,the group A had the shortest postoperative drainage and hospital stay,and the highest CD3+,CD4+,CD4+/CD8+and FEV1,FVC and MVV at 1 month after surgery(P＜0.05).One month after surgery,CD3+,CD4+,CD4+/CD8+,FEV1,FVC and MVV were lower than 1 day before surgery in the 4 groups.The total incidence of postoperative complications was lower in the group A than that of the other 3 groups(P＜0.05).Conclusion Non-intubated thoracoscopic surgery with epidural anesthesia and single operation hole can improve the clinical efficacy of NSCLC patients,reduce the dosage of opioids and have good safety.

Objective:To evaluate the cumulative relationship between individual cardiometabolic diseases(CMDs)and the incidence of cataract in the elderly.Methods:This study was a prospective cohort study based on the UK Biobank, including 165 222 participants without cataract at baseline, aged 60.0 to 74.0 years, with an average age of(64.9±2.9)years, including 76 712 males(46.4%)and 88 510 females(53.6%). The exposure in this study was CMDs(including coronary heart disease, stroke, diabetes, and hypertension), and the outcome was the incidence of cataract.The Cox proportional hazards model was used to evaluate the cumulative hazard ratio( HR)and 95% confidence interval( CI)of the number of CMDs and cataract occurrence in the elderly. Results:After a median follow-up of 13.65 years, 35, 933 cataract events were observed.After adjusting for various factors, the HRs of cataract incidence in elderly patients with 1, 2, and 3 or more CMDs compared with those without CMDs were 1.11( HR=1.11, 95% CI: 1.08~1.14, P<0.001), 1.38( HR=1.38, 95% CI: 1.33~1.43, P<0.001), and 1.80( HR=1.80, 95% CI: 1.68-1.93, P<0.001), respectively.There was a significant dose-cumulative effect between the number of CMDs and the risk of cataract( HR=1.17, 95% CI: 1.15~1.19, P<0.001). Conclusions:The coexistence of CMDs in the elderly is an important risk factor for cataract development, and the risk of cataract increases in a dose-cumulative manner with the increase in the number of CMDs, suggesting that emphasizing health management of CMDs in the elderly population may help reduce the incidence of cataract.

Depression is a prevalent mental and emotional disor-der that often results in significant emotional disturbances,cog-nitive dysfunction,and memory impairments.It is characterized by a high incidence rate,a substantial disability burden,and limited therapeutic efficacy.Currently,the long-term use of medications for the treatment of depression can result in a range of adverse reactions,highlighting the urgent need to explore no-vel approaches that can effectively alleviate depressive symptoms while minimizing side effects.Curcumin,a natural polyphenolic compound derived from the rhizome of turmeric,demonstrates considerable potential in the prevention and treatment of depres-sion,owing to its diverse array of biological activities.In recent years,numerous studies have investigated the use of curcumin for the treatment of depression.This article aims to provide a comprehensive review of the mechanisms of action underlying curcumin's efficacy in treating depression.Specifically,it focu-ses on its ability to improve neurotransmitter imbalances,restore neural plasticity,alleviate neural damage,mitigate dysfunction of the hypothalamic-pituitary-adrenal(HPA)axis,regulate in-flammatory factors and neuroinflammatory signaling pathways,and inhibit oxidative stress.This review is intended to offer in-sights and methodological references for basic research on curcu-min,as well as for the development of novel therapeutic agents for the treatment of depression.

Aim To verify the therapeutic effect of the Qushi Huoxue decoction(QSHXF)on a mouse model of non-alcoholic fatty liver disease(NAFLD)using network pharmacology and experimental approaches,to examine the changes in the PI3K-AKT-lipid metabo-lism signaling pathway,and to elucidate its molecular mechanisms.Methods The potential active ingredi-ents and targets of the QSHXF were identified using the TCMSP platform.NAFLD-related genes were sourced from the GeneCards,PharmGkb,TTD,and OMIM data-bases.The intersection of drug targets and NAFLD treatment targets was analyzed to identify the key tar-gets of the QSHXF in treating NAFLD.The STRING database and Cytoscape 3.9.1 software were utilized to construct networks linking traditional Chinese medicine active ingredients to disease targets and PPI networks,allowing for the screening of key active ingredients and core targets.GO and KEGG enrichment analyses of the intersecting targets were conducted using R version 4.2.2.The NAFLD model was established by feeding mice a methionine-choline deficient diet for a duration of five weeks.Following successful modeling,low,me-dium,and high doses of the QSHXF were administered for intervention over a period of six weeks.The efficacy was verified and the underlying mechanisms were ex-plored using methods such as HE staining,Oil Red O staining,and Western blot analysis.Results The net-work pharmacology prediction indicated that QSHXF might effectively treat NAFLD through key components such as quercetin and kaempferol,as well as core tar-gets including STAT3,AKT1,and HIF1A.KEGG en-richment analysis further suggested that QSHXF might exert its therapeutic effects on NAFLD via signaling pathways such as AGE-RAGE and PI3K-AKT.Verifi-cation through animal experiments demonstrated that QSHXF could significantly reduce hepatic steatosis and lipid droplet accumulation in NAFLD mice.Specifical-ly,it markedly decreased serum levels of TC,TG,ALT,AST,and LDL,while increasing HDL levels.Addition-ally,the treatment significantly reduced the protein ex-pression levels of p-PI3K,p-AKT,SREBP-1c,FASN,and ACC1 in the liver.Conclusions QSHXF can sig-nificantly enhance liver function,improve blood lipid levels,and alleviate hepatic steatosis in NAFLD mice,with its mechanism potentially linked to the inhibition of the PI3K-AKT-lipid metabolism signaling pathway.

Depression is a prevalent mental and emotional disor-der that often results in significant emotional disturbances,cog-nitive dysfunction,and memory impairments.It is characterized by a high incidence rate,a substantial disability burden,and limited therapeutic efficacy.Currently,the long-term use of medications for the treatment of depression can result in a range of adverse reactions,highlighting the urgent need to explore no-vel approaches that can effectively alleviate depressive symptoms while minimizing side effects.Curcumin,a natural polyphenolic compound derived from the rhizome of turmeric,demonstrates considerable potential in the prevention and treatment of depres-sion,owing to its diverse array of biological activities.In recent years,numerous studies have investigated the use of curcumin for the treatment of depression.This article aims to provide a comprehensive review of the mechanisms of action underlying curcumin's efficacy in treating depression.Specifically,it focu-ses on its ability to improve neurotransmitter imbalances,restore neural plasticity,alleviate neural damage,mitigate dysfunction of the hypothalamic-pituitary-adrenal(HPA)axis,regulate in-flammatory factors and neuroinflammatory signaling pathways,and inhibit oxidative stress.This review is intended to offer in-sights and methodological references for basic research on curcu-min,as well as for the development of novel therapeutic agents for the treatment of depression.

Aim To verify the therapeutic effect of the Qushi Huoxue decoction(QSHXF)on a mouse model of non-alcoholic fatty liver disease(NAFLD)using network pharmacology and experimental approaches,to examine the changes in the PI3K-AKT-lipid metabo-lism signaling pathway,and to elucidate its molecular mechanisms.Methods The potential active ingredi-ents and targets of the QSHXF were identified using the TCMSP platform.NAFLD-related genes were sourced from the GeneCards,PharmGkb,TTD,and OMIM data-bases.The intersection of drug targets and NAFLD treatment targets was analyzed to identify the key tar-gets of the QSHXF in treating NAFLD.The STRING database and Cytoscape 3.9.1 software were utilized to construct networks linking traditional Chinese medicine active ingredients to disease targets and PPI networks,allowing for the screening of key active ingredients and core targets.GO and KEGG enrichment analyses of the intersecting targets were conducted using R version 4.2.2.The NAFLD model was established by feeding mice a methionine-choline deficient diet for a duration of five weeks.Following successful modeling,low,me-dium,and high doses of the QSHXF were administered for intervention over a period of six weeks.The efficacy was verified and the underlying mechanisms were ex-plored using methods such as HE staining,Oil Red O staining,and Western blot analysis.Results The net-work pharmacology prediction indicated that QSHXF might effectively treat NAFLD through key components such as quercetin and kaempferol,as well as core tar-gets including STAT3,AKT1,and HIF1A.KEGG en-richment analysis further suggested that QSHXF might exert its therapeutic effects on NAFLD via signaling pathways such as AGE-RAGE and PI3K-AKT.Verifi-cation through animal experiments demonstrated that QSHXF could significantly reduce hepatic steatosis and lipid droplet accumulation in NAFLD mice.Specifical-ly,it markedly decreased serum levels of TC,TG,ALT,AST,and LDL,while increasing HDL levels.Addition-ally,the treatment significantly reduced the protein ex-pression levels of p-PI3K,p-AKT,SREBP-1c,FASN,and ACC1 in the liver.Conclusions QSHXF can sig-nificantly enhance liver function,improve blood lipid levels,and alleviate hepatic steatosis in NAFLD mice,with its mechanism potentially linked to the inhibition of the PI3K-AKT-lipid metabolism signaling pathway.

Objective To explore the current status,hotspots,and frontier directions in the field of hospital research management.Methods Literature related to hospital research management published from January 1987 to March 2025,as in-dexed in the China National Knowledge Infrastructure(CNKI),was retrieved.The visualization software CiteSpace was used to analyze the publication volume,authors,institutions,and keywords.Results A total of 250 Chinese-language articles were in-cluded.The overall publication volume showed a fluctuating upward trend,with the highest number of publications in 2023,reac-hing 26 articles.Notable institutions with higher publication volumes include Chongqing Traditional Chinese Medicine Hospital,the Medical Department of Nanjing General Hospital of the Nanjing Military Region,Tianjin Medical University Cancer Hospital,and Shengjing Hospital of China Medical University.Key authors with more publications include Zhou Laixin,Xu Dixiong,Liu Yuping,and Sun Meng.High-frequency keywords included"research management","hospital","research projects","re-search funding","public hospitals",and"project management",generating 11 clustering labels and 25 emerging terms.Con-clusion The research on hospital research management in China has evolved from conceptual definition and systematic construc-tion to the exploration of innovative strategies,with increasing depth and breadth.The field has yet to form a large-scale,cross-regional author and institutional cooperation network.High-frequency keywords such as"research management","hospital","research projects","research funding","public hospitals",and"project management"represent hotspots in the research.Keywords such as"public hospitals","design",and"research projects"may become the frontier directions for future research in this field.